Skip to main content
. 2020 Mar 16;36(4):243–248. doi: 10.3393/ac.2019.10.16.1

Table 3.

Operative outcomes of patients with CD in the upper GI tract and other sites

Variable Upper GI CD (n = 24) Other site CD (n = 787) P-value
Postoperative pRBC transfusion (unit) 7.04 ± 18.24 1.64 ± 3.84 0.001*
Operative time (min) 196 ± 68 158 ± 64 0.013*
Hospital stay after surgery (day) 27.5 ± 49.8 12.8 ± 13.0 0.001*
Total complications 10 (41.7) 193 (24.6) 0.16
 Intra-abdominal infection 5 (20.8) 72 (9.2) 0.07
 Bleeding 0 (0) 23 (2.9) 0.72
 Wound 2 (8.3) 70 (8.9) 0.64
 Anastomotic leak 4 (16.7) 28 (3.6) 0.012*
 Postoperative ileus 3 (12.5) 22 (2.8) 0.034*
 Entero-cutaneous fistula 0 (0) 4 (0.5) 0.89
Clinical recurrence, yes 15 (62.5) 467 (59.3) 0.001*
Mean time to clinical recurrence (mo) 39 ± 23 35 ± 27 0.54
Surgical recurrence, yes 4 (16.7) 90 (11.4) 0.001*
Mean time to surgical recurrence (mo) 77 ± 19 49 ± 34 0.055

Values are presented as mean±standard deviation or number (%).

CD, Crohn disease; GI, gastrointestinal; pRBC, packed red blood cell.

*

P<0.05, significant differences.